World of DTC Marketing

JULY 15, 2021

It’s never good to receive a letter from Congress that begins, “The Committee on Oversight and Reform and the Committee on Energy and Commerce is investigating the approval process for Biogen’s new Alzheimer’s drug.” Biogen’s reputation is damaged beyond repair, in my opinion.

Food and Drug Administration 202

Food and Drug Administration FDA Side effects Ethics 202

Pharmaceutical Technology

MARCH 7, 2023

Topline results of the Visionary trial (NCT03536559) were presented by the company in August last year, showing a significant improvement in the low contrast letter acuity (LCLA) score relative to placebo (least squares mean difference of 3.13) after 48 weeks.

Side effects 100

Side effects Patients Leads Safety 100

Pharmaceutical Representative Training

JANUARY 11, 2021

Do not overuse capital letters or underlines. In my opinion, years of experience will dictate the appropriate length of a resume. Instead of having a cover letter as an attachment, consider incorporating a strong email intro to act as a brief cover letter and resume highlights. Make sure that your fonts are big enough.

Sales 52

Sales Pharma Recruitment Pharma sales reps 52

Contrarian Sales Techniques

APRIL 26, 2022

A letter of appointment is a contract by a pharmaceutical or medical related company in which the medical executive can work with customers or suppliers with whom they connect. They often interact with their key opinion leaders (KOL) to build strong professional relationships. Medical Sales Executive Job Description 1.

Medical sales 52

Medical sales Medical Sales Doctors 52

Contrarian Sales Techniques

APRIL 19, 2022

A letter of appointment is a contract by a pharmaceutical or medical related company in which the medical rep can work with customers or suppliers with whom they connect. They often interact with their key opinion leaders (KOL) to build strong professional relationships. Job Scope Of A Medical Sales Representative 1.

Medical sales 52

Medical sales Medical Sales Doctors 52

Contrarian Sales Techniques

APRIL 26, 2022

A letter of appointment is a contract by a pharmaceutical or medical related company in which the medical executive can work with customers or suppliers with whom they’re connected to. They often interact with their key opinion leaders (KOL) to build strong professional relationships.

Medical sales 52

Medical sales Medical Sales Doctors 52

Contrarian Sales Techniques

JANUARY 30, 2023

In my personal opinion, while the earning potential in medical sales is high, it is not an easy job, it requires a lot of work, dedication, and persistence. This will give you a better understanding of what to expect and help you tailor your resume and cover letter to the industry.

Medical sales 52

Medical sales Sales Medical Healthcare Provider 52

Pharma Leaders

JUNE 27, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

JUNE 22, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 19, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 17, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 12, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 11, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 9, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 8, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 5, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 3, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MAY 1, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

APRIL 20, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

APRIL 18, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

APRIL 14, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

APRIL 7, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

APRIL 4, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

APRIL 3, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

Pharma Leaders

MARCH 27, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 52

FDA Manufacturing Pharmaceutical Pharma 52

European Pharmaceutical Review

OCTOBER 31, 2023

Alfasigma has signed a letter of intent to acquire Jyseleca – a JAK1 preferential inhibitor – from Galapagos for up to €170 million, plus royalties on European sales. The European Medicines Agency’s (EMA) human medicines committee (CHMP) adopted a positive opinion for Jyseleca for RA in July 2020.

Sales 88

Sales Medicine Marketing Medical 88

Pharma Leaders

JUNE 20, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Patients Manufacturing Pharmaceutical 40

Pharma Leaders

JUNE 15, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

Pharma Leaders

JUNE 14, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

Safety 40

Safety FDA Manufacturing Pharmaceutical 40

Pharma Leaders

JUNE 9, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

Pharma Leaders

JUNE 6, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

Pharma Leaders

JUNE 2, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

Pharma Leaders

JUNE 1, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

Pharma Leaders

MAY 31, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

Pharma Leaders

MAY 25, 2023

Don’t waste your time on unending, unproductive online searches for news stories, reports and opinion; let DID’s experienced in-house editorial team do the work for you. Use your energy where it’s needed most — ensuring that your products are in compliance and getting to market as quickly as possible.

FDA 40

FDA Manufacturing Pharmaceutical Pharma 40

European Pharmaceutical Review

FEBRUARY 23, 2023

These are solely my personal opinions derived from recent and 25 years of experience in the pharmaceutical industry, supporting firms, microbiologists, industry organisations, compendia and standard-setting bodies. I would add that these do not necessarily represent the opinions of those organisations I support or work for. 2022;13.

Pharmaceutical 94

Pharmaceutical Management Manufacturing Recruitment 94

Pharma Marketing Network

JUNE 11, 2020

And I was surprised to see a letter on the homepage that said, “Hey, Pharma folks, I’m retiring. So in my newsletter, I would have the front page would be like, three 400 words, that I could write my opinion every month. Don Langsdorf (EHS): You’d mentioned 14 letters that the FDA sent. John Mack (PG): No, no.

Media 52

Media Pharma Ethics Consulting 52